User profiles for Steven Drews
 | Steven DrewsCanadian Blood Services Verified email at blood.ca Cited by 8485 |
Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients
While the antibody response to SARS-CoV-2 has been extensively studied in blood,
relatively little is known about the antibody response in saliva and its relationship to systemic …
relatively little is known about the antibody response in saliva and its relationship to systemic …
Respiratory syncytial virus: infection, detection, and new options for prevention and treatment
Respiratory syncytial virus (RSV) infection is a significant cause of hospitalization of children
in North America and one of the leading causes of death of infants less than 1 year of age …
in North America and one of the leading causes of death of infants less than 1 year of age …
[HTML][HTML] Association between the 2008–09 seasonal influenza vaccine and pandemic H1N1 illness during spring–summer 2009: four observational studies from …
…, I Rouleau, M Petric, K Fonseca, SJ Drews… - PLoS …, 2010 - journals.plos.org
Background In late spring 2009, concern was raised in Canada that prior vaccination with the
2008–09 trivalent inactivated influenza vaccine (TIV) was associated with increased risk of …
2008–09 trivalent inactivated influenza vaccine (TIV) was associated with increased risk of …
[HTML][HTML] A simple protein-based surrogate neutralization assay for SARS-CoV-2
…, M Ostrowski, KA McDonough, MA Drebot, SJ Drews… - JCI insight, 2020 - ncbi.nlm.nih.gov
Most of the patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
mount a humoral immune response to the virus within a few weeks of infection, but the …
mount a humoral immune response to the virus within a few weeks of infection, but the …
A perfect storm: impact of genomic variation and serial vaccination on low influenza vaccine effectiveness during the 2014–2015 season
Background. The 2014–2015 influenza season was distinguished by an epidemic of
antigenically-drifted A(H3N2) viruses and vaccine components identical to 2013–2014. We report …
antigenically-drifted A(H3N2) viruses and vaccine components identical to 2013–2014. We report …
Shiga Toxin–Producing Escherichia coli Infection, Antibiotics, and Risk of Developing Hemolytic Uremic Syndrome: A Meta-analysis
Background. Antibiotic administration to individuals with Shiga toxin–producing Escherichia
coli (STEC) infection remains controversial. We assessed if antibiotic administration to …
coli (STEC) infection remains controversial. We assessed if antibiotic administration to …
Influenza vaccine effectiveness in preventing influenza-associated hospitalizations during pregnancy: a multi-country retrospective test negative design study, 2010 …
… Steven J Drews , Steven J Drews … Mark G Thompson, Jeffrey C Kwong, Annette K Regan,
Mark A Katz, Steven J Drews, Eduardo Azziz-Baumgartner, Nicola P Klein, Hannah Chung, …
Mark A Katz, Steven J Drews, Eduardo Azziz-Baumgartner, Nicola P Klein, Hannah Chung, …
A scalable serology solution for profiling humoral immune responses to SARS‐CoV‐2 infection and vaccination
Objectives Antibody testing against severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)
has been instrumental in detecting previous exposures and analyzing vaccine‐…
has been instrumental in detecting previous exposures and analyzing vaccine‐…
Practical guidance for clinical microbiology laboratories: viruses causing acute respiratory tract infections
Respiratory viral infections are associated with a wide range of acute syndromes and
infectious disease processes in children and adults worldwide. Many viruses are implicated in …
infectious disease processes in children and adults worldwide. Many viruses are implicated in …
Serial vaccination and the antigenic distance hypothesis: effects on influenza vaccine effectiveness during A (H3N2) epidemics in Canada, 2010–2011 to 2014–2015
Background. The antigenic distance hypothesis (ADH) predicts that negative interference from
prior season’s influenza vaccine (v1) on the current season’s vaccine (v2) protection may …
prior season’s influenza vaccine (v1) on the current season’s vaccine (v2) protection may …